These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23311138)

  • 1. [Application of secretary luciferase labeled orthotopic transplant model of hepatocellular carcinoma to evaluate tumor response to interferon-beta gene therapy].
    Wang G; Lian Z; Tian W; Dong X; Yuchi J; Wu X
    Sheng Wu Gong Cheng Xue Bao; 2012 Oct; 28(10):1236-44. PubMed ID: 23311138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Real time ex vivo detection and dynamic monitoring of in vivo expression of secreted luciferase gene injected by hydrodynamic method].
    Tian W; Wang G; Luo S; Dong X; Fu X; Tan W; Wu X
    Sheng Wu Gong Cheng Xue Bao; 2009 Oct; 25(10):1552-7. PubMed ID: 20112701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum-based tracking of de novo initiated liver cancer progression reveals early immunoregulation and response to therapy.
    Subleski JJ; Scarzello AJ; Alvord WG; Jiang Q; Stauffer JK; Kronfli A; Saleh B; Back T; Weiss JM; Wiltrout RH
    J Hepatol; 2015 Nov; 63(5):1181-9. PubMed ID: 26143441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
    Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of transgene-expressing cells by a specific immune response induced by sustained transgene expression.
    Yin Y; Takahashi Y; Ebisuura N; Nishikawa M; Takakura Y
    J Gene Med; 2014; 16(3-4):97-106. PubMed ID: 24807854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a dual-color fluorescence tracing orthotopic transplantation model of hepatocellular carcinoma.
    Chen Q; Wang X; Wu H; Wang H; Zhu M; Wang R; Wu Y; Zhang L; Meng Q; Song R; Zhuang Z; Huang Q
    Mol Med Rep; 2016 Jan; 13(1):762-8. PubMed ID: 26647736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of an orthotopic transplantation tumor model of hepatocellular carcinoma in mice.
    Zhao GJ; Xu LX; Chu ES; Zhang N; Shen JY; Damirin A; Li XX
    World J Gastroenterol; 2012 Dec; 18(47):7087-92. PubMed ID: 23323012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector.
    Kim KI; Park JH; Lee YJ; Lee TS; Park JJ; Song I; Nahm SS; Cheon GJ; Lim SM; Chung JK; Kang JH
    J Gene Med; 2012 Aug; 14(8):513-20. PubMed ID: 22761128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
    Sawahara H; Shiraha H; Uchida D; Kato H; Kato R; Oyama A; Nagahara T; Iwamuro M; Horiguchi S; Tsutsumi K; Mandai M; Mimura T; Wada N; Takeuchi Y; Kuwaki K; Onishi H; Nakamura S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Yagi T; Nasu Y; Kumon H; Okada H
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1769-1777. PubMed ID: 28168749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
    El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
    J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice.
    Wolschek MF; Thallinger C; Kursa M; Rössler V; Allen M; Lichtenberger C; Kircheis R; Lucas T; Willheim M; Reinisch W; Gangl A; Wagner E; Jansen B
    Hepatology; 2002 Nov; 36(5):1106-14. PubMed ID: 12395320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinoma.
    Makita Y; Murata S; Katou Y; Kikuchi K; Uejima H; Teratani M; Hoashi Y; Kenjo E; Matsumoto S; Nogami M; Otake K; Kawamata Y
    Biochem Biophys Res Commun; 2017 Nov; 493(1):800-806. PubMed ID: 28843857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma.
    Wang L; Su W; Liu Z; Zhou M; Chen S; Chen Y; Lu D; Liu Y; Fan Y; Zheng Y; Han Z; Kong D; Wu JC; Xiang R; Li Z
    Biomaterials; 2012 Jul; 33(20):5107-14. PubMed ID: 22494888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging.
    Sia KC; Huynh H; Chinnasamy N; Hui KM; Lam PY
    Gene Ther; 2012 May; 19(5):532-42. PubMed ID: 21918545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC).
    Rajasekaran D; Srivastava J; Ebeid K; Gredler R; Akiel M; Jariwala N; Robertson CL; Shen XN; Siddiq A; Fisher PB; Salem AK; Sarkar D
    Bioconjug Chem; 2015 Aug; 26(8):1651-61. PubMed ID: 26079152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
    Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
    Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous Tumor Cell Lysate-Loaded Dendritic Cell Vaccine Inhibited Tumor Progression in an Orthotopic Murine Model for Hepatocellular Carcinoma.
    Wang Q; Luan W; Warren L; Kadri H; Kim KW; Goz V; Blank S; Isabel Fiel M; Hiotis SP
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):574-582. PubMed ID: 26786094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recombinant adeno-associated virus type 8 mediated dual-luciferase gene expression in mouse].
    Wang G; Yu CJ; Dong XY; Tian WH; Wu XB
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):439-41. PubMed ID: 23627024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
    Yoon SK; Armentano D; Wands JR; Mohr L
    Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bone marrow-derived mesenchymal stromal cells on hepatoma.
    Abd-Allah SH; Shalaby SM; El-Shal AS; Elkader EA; Hussein S; Emam E; Mazen NF; El Kateb M; Atfy M
    Cytotherapy; 2014 Sep; 16(9):1197-206. PubMed ID: 24985939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.